Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribados: Ribavirin Once Daily vs Twice Daily in Hepatitis C
NCT00484328Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2007
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis C (HCV), sponsored by Maastricht University Medical Center+. Started Jul 2007; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00484328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484328.